The DOI matches its Crossref record.
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, treatment with tocilizumab ameliorated anti-AQP4 antibody production in the serum of NMO patients and suppressed relapse rate and neuropathic pain in patients with refractory NMO, suggesting its clinical efficacy in this condition (Araki et al., 2014”
From Targeting Interleukin-6 Signaling in Clinic (2019) · cites this paper as Araki et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 10
- 10.1038/nrneurol.2010.72 · DOI
- 10.1177/1756285608093978 · DOI
- 10.1073/pnas.1017385108 · DOI
- 10.1146/annurev-pharmtox-010611-134715 · DOI
- 10.3109/s10165-012-0715-9 · DOI
- 10.1001/archneurol.2012.768 · DOI
- 10.1212/WNL.0b013e318229e694 · DOI
- 10.1111/j.1533-2500.2010.00367.x · DOI
- 10.1523/JNEUROSCI.1822-09.2009 · DOI
- 10.1001/jamaneurol.2013.1246 · DOI
Cited by
Sorted by citations
Targeting Interleukin-6 Signaling in Clinic
Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 904
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
Faissner, S., Plemel, J. R., Gold, R., & Yong, V. W. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0035-2 · Cited by 459
Zhang, C., Zhang, M., Qiu, W., Ma, H., Zhang, X., Zhu, Z., Yang, C.-S., Jia, D., Zhang, T.-X., Yuan, M., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30070-3 · Cited by 287
IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
Kishimoto, T., & Kang, S. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101220-023458 · Cited by 140
Mealy, M. A., Kozachik, S. L., & Levy, M. (2019) · Pain Management Nursing · doi:10.1016/j.pmn.2019.03.003 · Cited by 20
Metadata
- Authors
- Araki, M., Matsuoka, T., Miyamoto, K., Kusunoki, S., Okamoto, T., Murata, M., Miyake, S., Aranami, T., & Yamamura, T.
- Affiliations
- From the Multiple Sclerosis Center (M.A., T.O., S.M., T.A., T.Y.) and Department of Neurology (T.O., M.M.), National Center Hospital, and Department of Immunology, National Institute of Neuroscience (T.M., S.M., T.A., T.Y.), National Center of Neurology and Psychiatry, Tokyo; Department of Neurology (K.M., S.K.), Kinki University School of Medicine, Osaka; and Department of Pediatrics (T.M.), Graduate School of Medicine, University of Tokyo, Japan.
- Venue
- Neurology
- Published
- 2014-04-15
- Volume
- 82
- Issue
- 15
- Pages
- 1302-1306
- ISSN
- 0028-3878
- 1526-632X
- PMC
- PMC4001188
- Cited by
- 284
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. https://app.cochat.ai/papers/10.1212/wnl.0000000000000317
- The paper
- Araki, M., Matsuoka, T., Miyamoto, K., Kusunoki, S., Okamoto, T., Murata, M., Miyake, S., Aranami, T., & Yamamura, T. (2014). Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology. https://doi.org/10.1212/wnl.0000000000000317
